These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8391709)

  • 1. A molecular modelling study on the hormone binding site of the estrogen receptor.
    Höltje HD; Dall N
    Pharmazie; 1993 Apr; 48(4):243-9. PubMed ID: 8391709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.
    Wurtz JM; Egner U; Heinrich N; Moras D; Mueller-Fahrnow A
    J Med Chem; 1998 May; 41(11):1803-14. PubMed ID: 9599231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
    Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
    Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gamma.
    Nam K; Marshall P; Wolf RM; Cornell W
    Biopolymers; 2003 Jan; 68(1):130-8. PubMed ID: 12579585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of 3D models of octopus estrogen receptor with estradiol: evidence for steric clashes that prevent estrogen binding.
    Baker ME; Chandsawangbhuwana C
    Biochem Biophys Res Commun; 2007 Sep; 361(3):782-8. PubMed ID: 17678875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.
    Mor M; Rivara S; Silva C; Bordi F; Plazzi PV; Spadoni G; Diamantini G; Balsamini C; Tarzia G; Fraschini F; Lucini V; Nonno R; Stankov BM
    J Med Chem; 1998 Sep; 41(20):3831-44. PubMed ID: 9748358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding site structure of one LRP-RAP complex: implications for a common ligand-receptor binding motif.
    Jensen GA; Andersen OM; Bonvin AM; Bjerrum-Bohr I; Etzerodt M; Thøgersen HC; O'Shea C; Poulsen FM; Kragelund BB
    J Mol Biol; 2006 Sep; 362(4):700-16. PubMed ID: 16938309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.
    Bhat RA; Stauffer B; Unwalla RJ; Xu Z; Harris HA; Komm BS
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):17-26. PubMed ID: 15026080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 17alpha-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain.
    Hanson RN; Lee CY; Friel CJ; Dilis R; Hughes A; DeSombre ER
    J Med Chem; 2003 Jul; 46(14):2865-76. PubMed ID: 12825929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectroscopic determination of the binding affinity of zinc to the DNA-binding domains of nuclear hormone receptors.
    Payne JC; Rous BW; Tenderholt AL; Godwin HA
    Biochemistry; 2003 Dec; 42(48):14214-24. PubMed ID: 14640689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity.
    Salum LB; Polikarpov I; Andricopulo AD
    J Chem Inf Model; 2008 Nov; 48(11):2243-53. PubMed ID: 18937440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular model of binding of estradiol and 8-isoestradiol with estrogen alpha-receptor].
    Shavva AG; Vlasova KV; Tsogoeva SB; Egorov MS; Iakutseni PP
    Bioorg Khim; 2002; 28(3):236-41. PubMed ID: 12077849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical evidence of a salt bridge disruption as the initiating process for the alpha1d-adrenergic receptor activation: a molecular dynamics and docking study.
    Carrieri A; Centeno NB; Rodrigo J; Sanz F; Carotti A
    Proteins; 2001 Jun; 43(4):382-94. PubMed ID: 11340655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous expression of soluble, active proteins in Escherichia coli: the human estrogen receptor hormone-binding domain as paradigm.
    Nygaard FB; Harlow KW
    Protein Expr Purif; 2001 Apr; 21(3):500-9. PubMed ID: 11281726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineation of the peptide binding site of the human galanin receptor.
    Kask K; Berthold M; Kahl U; Nordvall G; Bartfai T
    EMBO J; 1996 Jan; 15(2):236-44. PubMed ID: 8617199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.